1247735
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 6, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Summit, NJ (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)